LOINC_NUM
stringlengths
3
8
COMPONENT
stringlengths
2
246
PROPERTY
stringlengths
1
29
TIME_ASPCT
stringlengths
1
15
SYSTEM
stringlengths
1
106
SCALE_TYP
stringclasses
10 values
METHOD_TYP
stringlengths
1
57
CLASS
stringlengths
2
24
CLASSTYPE
int64
1
4
LONG_COMMON_NAME
stringlengths
3
254
SHORTNAME
stringlengths
2
51
EXTERNAL_COPYRIGHT_NOTICE
stringlengths
39
2.6k
STATUS
stringclasses
4 values
VersionFirstReleased
stringlengths
1
7
VersionLastChanged
stringlengths
1
5
99269-3
Clonazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Clonazolam [Mass/volume] in Urine by Confirmatory method
Clonazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99270-1
8-Aminoclonazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method
8-Aminoclonazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99271-9
Flualprazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Flualprazolam [Mass/volume] in Urine by Confirmatory method
Flualprazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99272-7
Alpha-hydroxy flualprazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method
A-OH flualprazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99273-5
Meclonazepam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Meclonazepam [Mass/volume] in Urine by Confirmatory method
Meclonazepam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99274-3
Flubromazepam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Flubromazepam [Mass/volume] in Urine by Confirmatory method
Flubromazepam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
9927-5
Q wave depth.lead AVR
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead AVR
Q wave Dpth L-AVR
null
ACTIVE
1.0i
2.48
99275-0
Phenazepam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Phenazepam [Mass/volume] in Urine by Confirmatory method
Phenazepam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99276-8
3-Hydroxyphenazepam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
3-Hydroxyphenazepam [Mass/volume] in Urine by Confirmatory method
3-OH-phenazepam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99277-6
Pyrazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Pyrazolam [Mass/volume] in Urine by Confirmatory method
Pyrazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99278-4
Flubromazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Flubromazolam [Mass/volume] in Urine by Confirmatory method
Flubromazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
99279-2
Alpha-hydroxy flubromazolam
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Alpha-hydroxy flubromazolam [Mass/volume] in Urine by Confirmatory method
A-OH flubromazolam Ur Cfm-mCnc
null
ACTIVE
2.72
2.72
992-8
D little o super little a Ab
PrThr
Pt
Ser/Plas^Donor
Ord
null
BLDBK
1
Do sup(a) Ab [Presence] in Serum or Plasma from Donor
Do sup(a) Ab SerPl Donr Ql
null
ACTIVE
1.0
2.56
99280-0
Cefiderocol
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Cefiderocol [Susceptibility]
Cefiderocol Susc Islt
null
ACTIVE
2.72
2.72
99281-8
Lefamulin
Susc
Pt
Isolate
OrdQn
null
ABXBACT
1
Lefamulin [Susceptibility]
Lefamulin Susc Islt
null
ACTIVE
2.72
2.72
99282-6
FDA-initiated compliance action drug registration and listing inactivation - animal drug
-
-
^FDA product label
Nar
null
DOC.REF
2
FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug
FDA animal drug+list inactivation
null
ACTIVE
2.72
2.72
9928-3
Q wave depth.lead I
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead I
Q wave Dpth L-I
null
ACTIVE
1.0i
2.48
99283-4
Tegner activity scale panel
-
Pt
^Patient
-
Tegner
PANEL.SURVEY.GNHLTH
4
Tegner Activity Scale panel [Tegner]
null
null
ACTIVE
2.72
2.72
99284-2
Activity level before injury
Find
Pt
^Patient
Nom
null
SURVEY.GNHLTH
4
Activity level before injury
null
null
ACTIVE
2.72
2.72
99285-9
Current activity level
Find
Pt
^Patient
Nom
null
SURVEY.GNHLTH
4
Current activity level
null
null
ACTIVE
2.72
2.72
99286-7
Provision of current reconciled medication list to subsequent provider at transfer
Find
Pt
^Patient
Ord
CMS Assessment
SURVEY.CMS
4
Provision of current reconciled medication list to subsequent provider at transfer [CMS Assessment]
null
null
ACTIVE
2.72
2.72
99287-5
Checklist of nonverbal pain indicators panel
-
Pt
^Patient
-
CNPI
PANEL.SURVEY.CNPI
4
Checklist of nonverbal pain indicators panel [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99288-3
Checklist of nonverbal pain indicators with movement panel
-
Pt
^Patient
-
CNPI
PANEL.SURVEY.CNPI
4
Checklist of nonverbal pain indicators with movement panel [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99289-1
Nonverbal vocal complaints during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Nonverbal vocal complaints during movement
null
null
ACTIVE
2.72
2.72
99290-9
Facial grimaces or winces during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Facial grimaces or winces during movement
null
null
ACTIVE
2.72
2.72
9929-1
Q wave depth.lead II
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead II
Q wave Dpth L-II
null
ACTIVE
1.0i
2.48
99291-7
Bracing during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Bracing during movement
null
null
ACTIVE
2.72
2.72
99292-5
Rubbing during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Rubbing during movement
null
null
ACTIVE
2.72
2.72
99293-3
Restlessness during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Restlessness during movement
null
null
ACTIVE
2.72
2.72
99294-1
Verbal complaints during movement
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Verbal complaints during movement
null
null
ACTIVE
2.72
2.72
99295-8
With movement score
Score
Pt
^Patient
Qn
CNPI
SURVEY.CNPI
4
With movement score [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99296-6
Checklist of nonverbal pain indicators at rest panel
-
Pt
^Patient
-
CNPI
PANEL.SURVEY.CNPI
4
Checklist of nonverbal pain indicators at rest panel [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99297-4
Nonverbal vocal complaints while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Nonverbal vocal complaints while at rest
null
null
ACTIVE
2.72
2.72
99298-2
Facial grimaces or winces while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Facial grimaces or winces while at rest
null
null
ACTIVE
2.72
2.72
99299-0
Bracing while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Bracing while at rest
null
null
ACTIVE
2.72
2.72
99300-6
Restlessness while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Restlessness while at rest
null
null
ACTIVE
2.72
2.72
99301-4
Rubbing while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Rubbing while at rest
null
null
ACTIVE
2.72
2.72
99302-2
Verbal complaints while at rest
Find
Pt
^Patient
Ord
null
SURVEY.CNPI
4
Verbal complaints while at rest
null
null
ACTIVE
2.72
2.72
99303-0
At rest score
Score
Pt
^Patient
Qn
CNPI
SURVEY.CNPI
4
At rest score [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99304-8
Total score
Score
Pt
^Patient
Qn
CNPI
SURVEY.CNPI
4
Total score [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99305-5
Checklist of nonverbal pain indicators assessment
Imp
Pt
^Patient
Nom
CNPI
SURVEY.CNPI
4
Checklist of nonverbal pain indicators assessment [CNPI]
null
Copyright. Karen S. Feldt, PhD, RN, GNP-BC Used with permission
ACTIVE
2.72
2.72
99306-3
Choriogonadotropin.beta subunit heterophile Ab interference panel
-
Pt
Ser
-
null
PANEL.CHEM
1
Choriogonadotropin.beta subunit heterophile Ab interference panel - Serum
B-HCG heterph Ab intrf Pnl Ser
null
ACTIVE
2.72
2.72
99307-1
Choriogonadotropin.beta subunit heterophile Ab interference
PrThr
Pt
Ser
Ord
null
CHEM
1
Choriogonadotropin.beta subunit heterophile Ab interference [Presence] in Serum
B-HCG heterph Ab intrf Ser Ql
null
ACTIVE
2.72
2.72
99308-9
Acid alpha glucosidase cross-reactive immunologic material (CRIM)
PrThr
Pt
WBC
Ord
IB
CHEM
1
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Leukocytes by Immunoblot
AAG CRIM WBC Ql IB
null
ACTIVE
2.72
2.72
9930-9
Q wave depth.lead III
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead III
Q wave Dpth L-III
null
ACTIVE
1.0i
2.48
99309-7
Acid alpha glucosidase cross-reactive immunologic material (CRIM)
PrThr
Pt
Tissue
Ord
IB
CHEM
1
Acid alpha glucosidase cross-reactive immunologic material (CRIM) [Presence] in Tissue by Immunoblot
AAG CRIM tiss Ql IB
null
ACTIVE
2.72
2.72
99310-5
Total score^^adjusted for age
Score
Pt
^Patient
Qn
null
CLIN.RISK
2
Total score age adjusted
Total score age-adj
null
ACTIVE
2.72
2.72
99311-3
Seizure onset
Type
Pt
^Patient
Nom
null
H&P.HX
2
Seizure onset
Seizure onset
null
ACTIVE
2.72
2.72
99312-1
Seizure frequency
Find
Pt
^Patient
Ord
null
H&P.HX
2
Seizure frequency
Seizure frequency
null
ACTIVE
2.72
2.72
99313-9
Time since last seizure
Find
Pt
^Patient
Ord
null
H&P.HX
2
Time since last seizure
Time since last seizure
null
ACTIVE
2.72
2.72
99314-7
SARS coronavirus 2 RdRp gene mutation detected
Prid
Pt
XXX
Nom
Molgen
MICRO
1
SARS-CoV-2 (COVID-19) RdRp gene mutation detected [Identifier] in Specimen by Molecular genetics method
SARS-CoV-2 RdRp mut Spec
null
ACTIVE
2.72
2.72
99315-4
OASIS E - Intervention synopsis - DC, TRN
-
Pt
^Patient
-
CMS Assessment
PANEL.SURVEY.CMS
4
OASIS E - Intervention synopsis - DC, TRN [CMS Assessment]
null
null
ACTIVE
2.72
2.72
9931-7
Q wave depth.lead V1
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V1
Q wave Dpth L-V1
null
ACTIVE
1.0i
2.48
9932-5
Q wave depth.lead V2
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V2
Q wave Dpth L-V2
null
ACTIVE
1.0i
2.48
9933-3
Q wave depth.lead V3
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V3
Q wave Dpth L-V3
null
ACTIVE
1.0i
2.48
9934-1
Q wave depth.lead V4
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V4
Q wave Dpth L-V4
null
ACTIVE
1.0i
2.48
99342-8
Days since symptom started
Find
Pt
^Patient
Ord
null
SURVEY.COVID
4
Days since symptom started
null
null
ACTIVE
2.72
2.72
99343-6
Days since symptom finished
Find
Pt
^Patient
Ord
null
SURVEY.COVID
4
Days since symptom finished
null
null
ACTIVE
2.72
2.72
99344-4
Sought medical attention for symptoms
Find
RptPeriod
^Patient
Nom
null
SURVEY.GNHLTH
4
Sought medical attention for symptoms
null
null
ACTIVE
2.72
2.72
99345-1
Type of medical attention accessed
Type
RptPeriod
^Patient
Nom
null
SURVEY.GNHLTH
4
Type of medical attention accessed
null
null
ACTIVE
2.72
2.72
99346-9
Temperature taken
Find
RptPeriod
^Patient
Ord
null
H&P.HX
2
Temperature taken Reporting Period
Temperature taken RptPeriod
null
ACTIVE
2.72
2.72
99347-7
Body temperature.max
Temp
RptPeriod
^Patient
Qn
null
H&P.HX
2
Maximum body temperature Reporting Period
Body temp.max RptPeriod
null
ACTIVE
2.72
2.72
99348-5
Close contact with COVID-19 in last 2W
Find
2W
^Patient
Nom
null
SURVEY.COVID
4
Close contact with COVID-19 in last 2W
null
null
ACTIVE
2.72
2.72
99349-3
Has or had COVID-19
Hx
Pt
^Patient
Ord
null
SURVEY.COVID
4
Has or had COVID-19
null
null
ACTIVE
2.72
2.72
99350-1
Date of first infection onset
Date
Pt
^Patient
Nom
null
SURVEY.COVID
4
Date of first infection onset
null
null
ACTIVE
2.72
2.72
99351-9
Informed of being at severe risk from COVID-19 due to an underlying health condition
Find
Pt
^Patient
Ord
null
SURVEY.COVID
4
Informed of being at severe risk from COVID-19 due to an underlying health condition
null
null
ACTIVE
2.72
2.72
99352-7
Has health problems that require activity limits
Find
Pt
^Patient
Ord
null
SURVEY.GNHLTH
4
Has health problems that require activity limits
null
null
ACTIVE
2.72
2.72
99353-5
Has health problems that require staying at home
Find
Pt
^Patient
Ord
null
H&P.HX
2
Has health problems that require staying at home
Health prob require stay home
null
ACTIVE
2.72
2.72
99354-3
Mobility device or aid is regularly used
Find
Pt
^Patient
Ord
null
H&P.HX
2
Mobility device or aid is regularly used
Mobility device reg used
null
ACTIVE
2.72
2.72
99355-0
Takes routine medication
Find
Pt
^Patient
Nom
null
H&P.HX
2
Takes routine medication
Takes routine med
null
ACTIVE
2.72
2.72
99356-8
Influenza virus vaccination received in last 12Mo
Find
12Mo
^Patient
Ord
null
H&P.HX
2
Influenza virus vaccination received in last 12 months
Flu vacc last 12Mo
null
ACTIVE
2.72
2.72
99357-6
COVID-19 health questions panel
-
Pt
^Patient
-
null
PANEL.SURVEY.COVID
4
COVID-19 health questions panel
null
null
ACTIVE
2.72
2.72
9935-8
Q wave depth.lead V5
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V5
Q wave Dpth L-V5
null
ACTIVE
1.0i
2.48
99359-2
Person who performed clinical measurement
Type
Pt
^Patient
Nom
null
H&P.HX
2
Person who performed clinical measurement
Clinical measurement by
null
ACTIVE
2.72
2.72
993-6
D little o super little a Ab
PrThr
Pt
Ser/Plas
Ord
null
BLDBK
1
Do sup(a) Ab [Presence] in Serum or Plasma
Do sup(a) Ab SerPl Ql
null
ACTIVE
1.0
2.73
99360-0
Bovine serum albumin Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Bovine serum albumin (BSA) IgG Ab [Mass/volume] in Serum
BSA IgG-mCnc
null
ACTIVE
2.72
2.72
99361-8
Horse hair+Horse dander Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Horse hair+Horse dander IgG Ab [Mass/volume] in Serum
Horse Hair+Dander IgG-mCnc
null
ACTIVE
2.72
2.72
99362-6
Euroglyphus maynei Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Euroglyphus maynei IgG Ab [Mass/volume] in Serum
E maynei IgG-mCnc
null
ACTIVE
2.72
2.72
99363-4
Triticum spelta Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Spelt IgG Ab [Mass/volume] in Serum
Spelt IgG-mCnc
null
ACTIVE
2.72
2.72
99364-2
Ovalbumin Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Ovalbumin IgG Ab [Mass/volume] in Serum
Ovalb IgG-mCnc
null
ACTIVE
2.72
2.72
99365-9
Sheep milk Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Sheep milk IgG Ab [Mass/volume] in Serum
Sheep Milk IgG-mCnc
null
ACTIVE
2.72
2.72
9936-6
Q wave depth.lead V6
Elpot
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave depth in lead V6
Q wave Dpth L-V6
null
ACTIVE
1.0i
2.48
99366-7
Chicken meat Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Chicken meat IgG Ab [Mass/volume] in Serum
Chicken Meat IgG-mCnc
null
ACTIVE
2.72
2.72
99367-5
Theobroma cacao Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Cocoa IgG Ab [Mass/volume] in Serum
Cocoa IgG-mCnc
null
ACTIVE
2.72
2.72
99368-3
Gliadin Ab.IgG
MCnc
Pt
Ser
Qn
null
SERO
1
Gliadin IgG Ab [Mass/volume] in Serum
Gliadin IgG Ser-mCnc
null
ACTIVE
2.72
2.72
99369-1
Dactylis glomerata Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Cocksfoot IgG Ab [Mass/volume] in Serum
Cocksfoot IgG-mCnc
null
ACTIVE
2.72
2.72
99370-9
Tabanus spp Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Horse Fly IgG Ab [Mass/volume] in Serum
Horse Fly IgG-mCnc
null
ACTIVE
2.72
2.72
99371-7
Culex pipiens Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Culex mosquito IgG Ab [Mass/volume] in Serum
Culex mosquito IgG-mCnc
null
ACTIVE
2.72
2.72
99372-5
Platanus acerifolia Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
London Plane IgG Ab [Mass/volume] in Serum
London Plane IgG-mCnc
null
ACTIVE
2.72
2.72
99373-3
Alnus incana Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Grey Alder IgG Ab [Mass/volume] in Serum
Grey Alder IgG-mCnc
null
ACTIVE
2.72
2.72
9937-4
Q wave duration.lead AVF
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave duration in lead AVF
Q wave dur L-AVF
null
ACTIVE
1.0i
2.48
99374-1
Betula verrucosa Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Silver Birch IgG Ab [Mass/volume] in Serum
Silver Birch IgG-mCnc
null
ACTIVE
2.72
2.72
99375-8
Corylus avellana pollen Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Hazelnut Pollen IgG Ab [Mass/volume] in Serum
Hazelnut Poln IgG-mCnc
null
ACTIVE
2.72
2.72
99376-6
Olea europaea pollen Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Olive Pollen IgG Ab [Mass/volume] in Serum
Olive Poln IgG-mCnc
null
ACTIVE
2.72
2.72
99377-4
Parietaria judaica Ab.IgG
MCnc
Pt
Ser
Qn
null
ALLERGY
1
Pellitory (Parietaria judaica) IgG Ab [Mass/volume] in Serum
Pellitory (judaic) IgG-mCnc
null
ACTIVE
2.72
2.72
99378-2
Vasopressin
SCnc
Pt
Urine
Qn
null
CHEM
1
Vasopressin [Moles/volume] in Urine
Vasopressin Ur-sCnc
null
ACTIVE
2.72
2.72
99379-0
Mercury
SCnc
Pt
Milk
Qn
null
DRUG/TOX
1
Mercury [Moles/volume] in Milk
Mercury Mlk-sCnc
null
ACTIVE
2.72
2.72
99380-8
Mercury
SCnc
Pt
CSF
Qn
null
DRUG/TOX
1
Mercury [Moles/volume] in Cerebral spinal fluid
Mercury CSF-sCnc
null
ACTIVE
2.72
2.72
99381-6
Mercury
SCnc
Pt
Dial fld
Qn
null
DRUG/TOX
1
Mercury [Moles/volume] in Dialysis fluid
Mercury Dial fld-sCnc
null
ACTIVE
2.72
2.72
9938-2
Q wave duration.lead AVL
Time
Pt
Heart
Qn
EKG
EKG.MEAS
2
Q wave duration in lead AVL
Q wave dur L-AVL
null
ACTIVE
1.0i
2.48